# A Long-Term Follow-up Study of the Severe Parkinson's Disease Patients Administered the IPS101A Gene Therapy Product.

> **NCT07629115** · — · RECRUITING · sponsor: **Innopeutics Corporation** · enrollment: 6 (estimated)

## Conditions studied

- Parkinson Disease
- Parkinson's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07629115
- **Lead sponsor:** Innopeutics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-29
- **Primary completion:** 2031-07-30
- **Final completion:** 2031-10-30
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07629115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07629115, "A Long-Term Follow-up Study of the Severe Parkinson's Disease Patients Administered the IPS101A Gene Therapy Product.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07629115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*